Process View
Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of calcium mediated signaling"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
LCK | lymphocyte-specific protein tyrosine kinase | 0.998 | ||
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.908 | Mouse | |
CD247 | CD247 molecule | 0.873 | ||
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.832 | Mouse | |
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.815 | ||
SYK | spleen tyrosine kinase | 0.563 | Mouse | |
CCR5 | chemokine (C-C motif) receptor 5 | 0.531 | ||
LAT | linker for activation of T cells | 0.484 | ||
UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 0.125 | ||
PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.096 | ||
DSG2 | desmoglein 2 | 0.096 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.092 | Human | |
CD2 | CD2 molecule | 0.064 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.063 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.052 | ||
ITGB1BP3 | integrin beta 1 binding protein 3 | 0.050 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.042 | ||
IL8 | interleukin 8 | 0.041 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.039 | Human | |
VAV1 | vav 1 guanine nucleotide exchange factor | 0.038 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.032 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.031 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.030 | Human | |
DPP4 | dipeptidyl-peptidase 4 | 0.025 | ||
CD3D | CD3d molecule, delta (CD3-TCR complex) | 0.025 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.023 | Human | |
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.022 | ||
IFNG | interferon, gamma | 0.022 | ||
SH2D1A | SH2 domain containing 1A | 0.021 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.021 | ||
IDE | insulin-degrading enzyme | 0.020 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.019 | ||
SH2D2A | SH2 domain containing 2A | 0.018 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.018 | ||
CD8B | CD8b molecule | 0.018 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.018 | ||
CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.018 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.017 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.017 | ||
HMG20A | high mobility group 20A | 0.015 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.015 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.015 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.014 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
PRKCQ | protein kinase C, theta | 0.013 | ||
IL2RB | interleukin 2 receptor, beta | 0.013 | ||
CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.012 | ||
IL1B | interleukin 1, beta | 0.012 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.011 | ||
TNF | tumor necrosis factor | 0.011 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.011 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.011 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.011 | ||
WASL | Wiskott-Aldrich syndrome-like | 0.010 |